D

Researcher Profile

Dongfang Tang

2

Publications

32

Citations

10

Co-Authors

2

Active Years

Publications

Open Access Journal Article Signal Transduction and Targeted Therapy Jun 14, 2024

Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study

Haoran Xia · Han Zhang · Zheng Ruan · Huibiao Zhang +25 more

10.1038/s41392-024-01861-w 22 citations

Open Access Journal Article Frontiers in Surgery Apr 05, 2022

Neoadjuvant Immuno-Chemotherapy: A New Perspective for Stage III NSCLC?

Yuanshan Yao · Dongfang Tang · Wen Gao · Huibiao Zhang

10.3389/fsurg.2022.843987 10 citations

Publication Timeline

2024

1

2022

1

Frequent Co-Authors